Sage Therapeutics Inc (SAGE)
13.25
+0.22
(+1.69%)
USD |
NASDAQ |
Apr 19, 15:53
Sage Therapeutics Cash from Investing (Quarterly): 42.06M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 42.06M |
| September 30, 2023 | 160.39M |
| June 30, 2023 | 45.59M |
| March 31, 2023 | 194.87M |
| December 31, 2022 | 89.78M |
| September 30, 2022 | 110.95M |
| June 30, 2022 | 134.26M |
| March 31, 2022 | -9.558M |
| December 31, 2021 | -30.26M |
| September 30, 2021 | -24.98M |
| June 30, 2021 | -288.39M |
| March 31, 2021 | -658.82M |
| December 31, 2020 | 45.52M |
| September 30, 2020 | 13.51M |
| June 30, 2020 | 177.38M |
| March 31, 2020 | 206.27M |
| December 31, 2019 | -17.92M |
| September 30, 2019 | 207.78M |
| June 30, 2019 | -58.11M |
| March 31, 2019 | -274.91M |
| December 31, 2018 | 38.42M |
| September 30, 2018 | 0.052M |
| Date | Value |
|---|---|
| June 30, 2018 | -238.13M |
| March 31, 2018 | -312.80M |
| December 31, 2017 | -104.60M |
| September 30, 2017 | 43.87M |
| June 30, 2017 | 44.59M |
| March 31, 2017 | 31.60M |
| December 31, 2016 | -117.94M |
| September 30, 2016 | -27.72M |
| June 30, 2016 | -84.02M |
| March 31, 2016 | -0.341M |
| December 31, 2015 | -0.038M |
| September 30, 2015 | 0.021M |
| June 30, 2015 | -0.071M |
| March 31, 2015 | -0.11M |
| December 31, 2014 | -0.045M |
| September 30, 2014 | -0.078M |
| June 30, 2014 | -0.002M |
| March 31, 2014 | -0.003M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | -0.003M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-658.82M
Minimum
Mar 2021
207.78M
Maximum
Sep 2019
17.91M
Average
45.52M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| Biogen Inc | -652.30M |
| Gilead Sciences Inc | -727.00M |
| Perspective Therapeutics Inc | -0.089M |
| QuidelOrtho Corp | -55.10M |
| Aethlon Medical Inc | -0.0088M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -119.52M |
| Cash from Financing (Quarterly) | -0.262M |
| Free Cash Flow | -541.14M |
| Free Cash Flow Per Share (Quarterly) | -1.990 |
| Free Cash Flow to Equity (Quarterly) | -119.41M |
| Free Cash Flow Yield | -68.25% |